Clinical Trial Update: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports the termination of a haploidentical hematopoietic stem cell transplantation study using reduced-intensity conditionin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Metabolic Disorders
• Sickle Cell Disease
• Thalassemia
• X-linked Adrenoleukodystrophy

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Sickle Cell Disease, Thalassemia | Phase 2 | Status: TERMINATED